Trial Profile
Paclitaxel poliglumex (CT-2103) [Xyotax] vs. paclitaxel for the treatment of women with chemotherapy-naive advanced non-small cell lung cancer who are performance status 2
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2020
Price :
$35
*
At a glance
- Drugs Paclitaxel poliglumex (Primary) ; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms PIONEER; PIONEER-1
- Sponsors CTI BioPharma
- 09 Dec 2006 Status change
- 07 Nov 2006 Status change
- 09 Dec 2005 New trial record.